Novartis Ireland Limited (Novartis Ireland Limited)
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Event / Reception (1)
HPP Advanced Therapies Roundtable held at the Royal College of Physicians of Ireland (RCPI), 25 March brought together key stakeholders from across healthcare, patient advocate leaders, policy and academia to discuss the opportunities and challenges associated with health system readiness and patient access to innovative treatments.
Email (31-50)
Invites to Roundtable and follow up emails from HPP to delegates regarding their outcome whitepaper.
Meeting (2-5)
Informal meeting with some interested public representatives to answer any questions about system shaping for advanced therapies ahead of participation in roundtable on the 3rd March in Buswells Hotel.
Informal communication (2-5)
Texts to ensure invites and information received
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.